Our ames is true: How an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer
- 1 November 1997
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 174 (5) , 462-468
- https://doi.org/10.1016/s0002-9610(97)00162-1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Basic Principles in Surgical OncologyArchives of Surgery, 1997
- The New Era in Breast CancerArchives of Surgery, 1996
- Oncoproteins and tumor progression in papillary thyroid carcinoma. Presence of epidermal growth factor receptor, c‐erbB‐2 protein, estrogen receptor related protein, p21‐ras protein, and proliferation indicators in relation to tumor recurrences and patient survivalCancer, 1995
- Breast Conservation Following Induction Chemotherapy for Locally Advanced Carcinoma of the Breast (Stages IIB aND III):Surgical Oncology Clinics of North America, 1995
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994
- Papillary thyroid carcinoma: The new, age‐related TNM classification system in a retrospective analysis of 199 patientsWorld Journal of Surgery, 1990
- A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. thyroid cancer cooperative groupPublished by Elsevier ,1979
- Risk factor analysis in differentiated thyroid cancerCancer, 1979
- Changing Clinical, Pathologic, Therapeutic, and Survival Patterns in Differentiated Thyroid CarcinomaAnnals of Surgery, 1976
- Papillary cancer of the thyroid. A review of 25 years of experienceCancer, 1958